GenePlanet: Funding, Investors & Team (Oct 2026)
GenePlanet is a biotechnology company based in Europe that focuses on genetic testing and research. They offer a range of preventative genetic tests for individuals, as well as clinical genetic tests to assist doctors in their treatments. GenePlanet is committed to maintaining high-quality standards and uses the most recent scientific advancements in their testing methods. Their services provide individuals with information to help them make lifestyle adjustments and take precautionary measures against health risks associated with their genetic predispositions.
GenePlanet has raised $22.3M across 1 funding round on record, the most recent a Series B of $22.3M announced in Jul 2023.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
GenePlanet Company Profile and Key Stats
Latest funding round on record: Jul 2023.
GenePlanet Funding Rounds
GenePlanet Founders and Leadership Team
Contact details for the GenePlanet team: 1 of 1 has an email address on file.
Start 14-day free trial →GenePlanet Funding Compared to Other Biotechnology Startups
GenePlanet's latest round of $22.3M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like GenePlanet in Biotechnology and Ljubljana
Companies Similar to GenePlanet
BioLinker is a creation of manufactured science, protein blend packs, and protein.
WhiteLab Genomics develops digital tools that help gene and cell therapy companies develop cheaper drugs…
Tydra Labs is a biotechnology company that transforms crustacean shell waste into chitin and bio-products.
M-Based develops new alternative material technologies using mushrooms. 🍄 We consider environmental…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Turning biomass residues into fit-for-purpose microbial fertilizers, biostimulants and biocontrols.
R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
GenePlanet Funding FAQs
What does GenePlanet do?
GenePlanet is a biotechnology company based in Europe that focuses on genetic testing and research. They offer a range of preventative genetic tests for individuals, as well as clinical genetic tests to assist doctors in their treatments. GenePlanet is committed to maintaining high-quality standards and uses the most recent scientific advancements in their testing methods. Their services provide individuals with information to help them make lifestyle adjustments and take precautionary measures against health risks associated with their genetic predispositions.
How much funding has GenePlanet raised?
GenePlanet has raised $22.3M across 1 round on record. The most recent is a Series B of $22.3M announced in Jul 2023.
When did GenePlanet last raise funding?
GenePlanet's most recent funding round on record is a Series B of $22.3M, announced in Jul 2023.
Who founded GenePlanet?
FundedIQ lists Masa Judar (Founder) at GenePlanet.
Where is GenePlanet headquartered?
GenePlanet is based in Ljubljana, Slovenia.
How many employees does GenePlanet have?
GenePlanet is in the 101-250 employee band.
How does GenePlanet's funding compare to other Biotechnology startups?
GenePlanet's latest round of $22.3M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's GenePlanet Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for GenePlanet is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.